Pharming Group NV - ADRPHAR
13F holders, Q3 2025 (September 30)9holders +5
5new positions
0sold out
$14.50avg. 13F price*
At the end of Q3 2025, 9 institutions reported holding Pharming Group NV - ADR (PHAR) in their 13F filings, up 5 from Q2 2025. 5 opened new positions and 0 sold out. The largest holders were Silverberg Bernstein Capital Management LLC ($756K), Morgan Stanley ($63K) and EverSource Wealth Advisors, LLC ($20K).
- Company
- Pharming Group NV - ADR
- CUSIP
- 71716E105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $5K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 1,836 shares bought and 1,602 shares sold, net +234 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Silverberg Bernstein Capital Management LLC | 0.46% | No change | 52,147 | $756K |
| Morgan Stanley | 0.00% | Add +50.2% | 4,355 | $63K |
| EverSource Wealth Advisors, LLC | 0.00% | Reduce -53.8% | 1,377 | $20K |
| Nalls Sherbakoff Group, LLC | 0.01% | No change | 870 | $13K |
| NewEdge Advisors, LLC | 0.00% | New | 253 | $4K |
| BNP Paribas Financial Markets | 0.00% | New | 100 | $1K |
| Global Retirement Partners, LLC | 0.00% | New | 23 | $334 |
| SBI Securities Co., Ltd. | 0.00% | New | 2 | $29 |
| Bessemer Group Inc. | 0.00% | New | 3 | $0 |
"% of holder's portfolio" is PHAR's weight in each manager's 13F, not the share of Pharming Group NV - ADR the manager owns.